Childhood vaccination schedule: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Mehdi Pahlavani (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
5,087 edits
Mehdi Pahlavani (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
5,087 edits
Line 33: Line 33:
|style="background: #AFEEEE; padding: 5px text-align:center" |
|style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="5" style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
| colspan="5" style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
|
| colspan="8" |
|
|
|
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Rotavirus2 (RV) RV1 (2-dose series);
|align="center" style="background:#DCDCDC;"|Rotavirus2 (RV) RV1 (2-dose series);
Line 69: Line 62:
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
|style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
|
| colspan="2" |
|
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |4th dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |4th dose
|
| colspan="2" |
|
|style="background: #F0E68C; padding: 5px text-align:center" |5th dose
|style="background: #F0E68C; padding: 5px text-align:center" |5th dose
|
|
Line 90: Line 81:
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |3rd or 4th dose,  
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |3rd or 4th dose,  
See footnote 4
See footnote 4
|
| colspan="4" |
|
| colspan="5" |
|
|
|
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate5 (PCV13)
|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate5 (PCV13)
Line 108: Line 92:
|
|
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |4th dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |4th dose
|
| colspan="4" |
|
| colspan="5" |
|
|
|
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Inactivated poliovirus6 (IPV: <18 yrs)
|align="center" style="background:#DCDCDC;"|Inactivated poliovirus6 (IPV: <18 yrs)
Line 124: Line 101:
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
| colspan="5" style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
| colspan="5" style="background: #F0E68C; padding: 5px text-align:center" |3rd dose
|
| colspan="2" |
|
|style="background: #F0E68C; padding: 5px text-align:center" |4th dose
|style="background: #F0E68C; padding: 5px text-align:center" |4th dose
|
| colspan="5" |
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Influenza7 (IIV)
|align="center" style="background:#DCDCDC;"|Influenza7 (IIV)
Line 148: Line 120:
| colspan="2" |See footnote 8
| colspan="2" |See footnote 8
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |1st dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |1st dose
|
| colspan="3" |
|
|
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|
| colspan="5" |
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Varicella9 (VAR)
|align="center" style="background:#DCDCDC;"|Varicella9 (VAR)
Line 166: Line 132:
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |1st dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |1st dose
|
| colspan="3" |
|
|
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
|
| colspan="5" |
|
|
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Hepatitis A1 0 (HepA)
|align="center" style="background:#DCDCDC;"|Hepatitis A1 0 (HepA)
Line 196: Line 156:
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|
| colspan="11" |
|
|
|
|
|
|
|
|
|
|
|style="background: #F0E68C; padding: 5px text-align:center" |1st dose
|style="background: #F0E68C; padding: 5px text-align:center" |1st dose
|
|
Line 227: Line 177:
|
|
|style="background:#F0E68C; |Tdap
|style="background:#F0E68C; |Tdap
|
| colspan="3" |
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Human papillomavirus1 3 (HPV)
|align="center" style="background:#DCDCDC;"|Human papillomavirus1 3 (HPV)
Line 246: Line 194:
|
|
|See footnote 13
|See footnote 13
|
| colspan="3" |
|
|
|-
|-
|align="center" style="background:#DCDCDC;"|Meningococcal B1 1
|align="center" style="background:#DCDCDC;"|Meningococcal B1 1
Line 280: Line 226:
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|
| colspan="7" |
|
|
|
|
|
|
|}
|}


Revision as of 20:18, 10 April 2017

Template:Vaccination schedule Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Childhood vaccination schedule

The following table summarizes the vaccination schedule for Adolescents Aged 18 Years or Younger based on CDC 2017 recommendation.

Vaccine Birth 1 mo 2 mos 4 mos 6 mos 9 mos 12 mos 15 mos 18 mos 19-23 mos 2-3 yrs 4-6 yrs 7-10 yrs 11-12 yrs 13-15 yrs 16 yrs 17-18 yrs
Hepatitis B1 (HepB) 1st dose 2nd dose 3rd dose
Rotavirus2 (RV) RV1 (2-dose series);

RV5 (3-dose series)

1st dose 2nd dose See footnote 2
Diphtheria, tetanus, & acellular pertussis3

(DTaP: <7 yrs)

1st dose 2nd dose 3rd dose 4th dose 5th dose
Haemophilus influenzae type b4 (Hib) 1st dose 2nd dose See footnote 4 3rd or 4th dose,

See footnote 4

Pneumococcal conjugate5 (PCV13) 1st dose 2nd dose 3rd dose 4th dose
Inactivated poliovirus6 (IPV: <18 yrs) 1st dose 2nd dose 3rd dose 4th dose
Influenza7 (IIV) Annual vaccination (IIV) 1 or 2 doses Annual vaccination (IIV) 1 dose only
Measles, mumps, rubella8 (MMR) See footnote 8 1st dose 2nd dose
Varicella9 (VAR) 1st dose 2nd dose
Hepatitis A1 0 (HepA) 2-dose series, See footnote 10
Meningococcal1 1 (Hib-MenCY >6 weeks;

MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)

1st dose 2nd dose
Tetanus, diphtheria, & acellular pertussis12 (Tdap: >7 yrs) Tdap
Human papillomavirus1 3 (HPV) See footnote 13
Meningococcal B1 1
Pneumococcal polysaccharide5 (PPSV23)

See also

Sources and notes

External links

  • National Center for Immunization and Respiratory Diseases. "CDC National Immunization Program". CDC. Retrieved 2006-09-18.
  • "MMR vaccine and the autism epidemic: In a compulsory inoculation program, it is the responsibility of the developers, promoters and enforcers to prove safety and efficacy". MMR vaccine and the autism epidemic. InformedChoice.info. Retrieved 2006-09-18.
  • National Health Service of UK. "UK Immunisation Schedule and Information". NHS. Retrieved 2006-11-03.

Template:Vaccines

de:Impfkalender id:Jadwal imunisasi


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Childhood_vaccination_schedule&oldid=1306267"